Search results

197 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Wang receives grant from the Lung Cancer Research Foundation
Andrew Wang, MD, assistant professor of radiation oncology, has been awarded a $50,000 one-year grant from the Lung Cancer Research Foundation.
Located in News / 2012 News
Haithcock talks about esophageal cancer in recent interview
Benjamin E. Haithcock, MD, an assistant professor in UNC's Division of Cardiothoracic Surgery and a member of UNC Lineberger, discussed esophageal cancer in an interview that was aired on the January 5, 2012 segment of the radio show "Make it Happen."
Located in News / 2012 News
Norman E. Sharpless, MD, appointed the Wellcome Distinguished Professor in Cancer Research
Chapel Hill, NC – Norman E. “Ned” Sharpless, MD, professor of medicine and genetics and Associate Director for Translational Research at UNC Lineberger Comprehensive Cancer Center has been appointed the Wellcome Distinguished Professor in Cancer Research. The professorship was established by the School of Medicine in 1988 with gifts from the Burroughs Wellcome Fund and the William A. Smith Trust of Wadesboro, NC. The gifts were supplemented by the state of North Carolina the Distinguished Professors Endowment Trust Fund to create the endowed professorship.
Located in News / 2012 News
UNC Lineberger scientists receive grant for pulmonary inflammation research
Three UNC Lineberger researchers are collaborating on a project recently awarded more than $3.3 million over five years from the National Institutes of Health’s National Heart, Lung, and Blood Institute.
Located in News / 2012 News
Norman E. Sharpless appointed Deputy Director of UNC Lineberger
Chapel Hill, NC – Norman E. “Ned” Sharpless, MD, has been appointed Deputy Director of the UNC Lineberger Comprehensive Cancer Center. Dr. Sharpless is the Wellcome Distinguished Professor in Cancer Research, professor of medicine and genetics.
Located in News / 2012 News
McLeod quoted on chemotherapy dosages in Genetic Engineering and Biotechnology News
Genetic Engineering and Biotechnology News interviwed Howard McLeod, PharmD, about the role of physicians and insurance companies in gauging chemotherapy dosages in an article titled "Chemotherapy for the 21st Century" published Oct. 31, 2012.
Located in News / 2012 News
UNC study highlights diagnosis of lung cancer subtypes
In the processes of treating most cancers, one of the key pieces of information is the appearance of the tumor under the microscope using a technique called light microscopy. In lung cancer, for example, the appearance of the tumor determines both which chemotherapies are safe and which chemotherapies are effective. In addition, tumor appearance also suggests which patients should be tested for mutations that can be targeted by some of the most effective and safest drugs on the market.
Located in News / 2012 News